SL Science Seeks FDA Orphan Drug Designation for Gamma Delta T Cell Therapy in Glioblastoma

SL Science Holding Limited (“SL Science” or the “Company”) (Nasdaq: SLBT), a Taiwan-headquartered biomedical company specializing...

July 13, 2026 | Monday | News
TaiMed Biologics Secures TFDA Drug License Notice for Trogarzo Ahead of Taiwan Launch

TaiMed Biologics (TPEX: 4147) announced that its HIV therapy Trogarzo (ibalizumab; English name: Trogarzo Injection; Chinese name: 佐加洛注射劑) ha...

July 09, 2026 | Thursday | News
Aligos Receives $25 Million Upfront Payment from Amoytop as Pevifoscorvir Sodium Secures Breakthrough Therapy Designation in China

Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapie...

July 08, 2026 | Wednesday | News
Caliway Biopharmaceuticals Secures U.S. FDA Clearance for Second Global Phase 3 Study of CBL-514

Asia-Pacific Phase 2 Study CBL-0206 Also Approved by Australia HREC and Taiwan TFDA, Accelerating Global Dual-Track Strategy U.S. ...

May 25, 2026 | Monday | News
MacroGenics Sells Maryland Biologics Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million

•MacroGenics to receive $122.5 million upfront payment from Bora upon closing•Transaction includes transfer of manufacturing site, CDMO operati...

May 13, 2026 | Wednesday | News
U.S.–Taiwan Biopharma Ties Deepen as PharmaEssentia Corporation Launches Puerto Rico Expansion

A pivotal step in PharmaEssentia's dual-site U.S.-Taiwan manufacturing strategy, with 2027 operations in sight PharmaEssentia Corporation (TWS...

April 06, 2026 | Monday | News
Terumo BCT and Taiwan Bio Collaborate to Automate Treg Therapy Manufacturing Using Quantum Flex Platform

Taiwan Bio will leverage the Quantum Flex™ Cell Expansion System 3-in-1 workflow beyond CAR-T to support&nb...

March 18, 2026 | Wednesday | News
AstraZeneca Deepens Weight Management Push With $1.2B AI-Driven Obesity Deal With CSPC

Agreement includes eight programmes, including a clinical-ready asset, plus access to advanced AI-driven peptide drug discovery platform and innovati...

February 03, 2026 | Tuesday | News
HanchorBio and WuXi Biologics Enter Strategic Collaboration to Advance Next-Generation Fusion Proteins

HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseas...

January 27, 2026 | Tuesday | News
Senhwa Biosciences Advances CX-5461 Into ADC Combinations With Enhertu® in NCI-Backed Phase 1b Trial

Following its recent clinical collaboration with the multinational pharmaceutical company BeOne Medicines to explore combination therapy with its markete...

December 30, 2025 | Tuesday | News
Foresee Pharmaceuticals’ FP-001 Meets Phase 3 Primary Endpoint in Central Precocious Puberty

The proportion of patients with serum luteinizing hormone (LH) suppression to < 4 mIU/mL at 60 minutes following a GnRHa stimula...

December 29, 2025 | Monday | News
Caliway Submits FDA IND for Phase 2 Study of CBL-514 in Combination With Eli Lilly’s Zepbound® for Weight Management

Caliway has completed submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 2 clinical...

December 26, 2025 | Friday | News
Antengene Expands XPOVIO® Approval in Malaysia to Relapsed or Refractory DLBCL

Antengene Corporation Limited, a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing fir...

December 18, 2025 | Thursday | News
GlycoNex Enters CDMO Agreement to Advance First-in-Class Anti-HMGB1 Antibody Into Clinical Trials in Japan

Collaboration with Science Tokyo spinout underscores GlycoNex's integrated antibody development and manufacturing capabilities in support of first-in-cla...

December 09, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close